InfoNet Logo

 New Mexico AIDS InfoNet

Fact Sheet Number 432

EFAVIRENZ (Sustiva)


Eslabón a la Versión Español

 PrinterPrint

this Fact Sheet on a single page using:

 Microsoft Word

Adobe Acrobat

 More information on Downloading

& Printing Fact Sheets


WHAT IS EFAVIRENZ?

Efavirenz is a drug used for antiviral

therapy. It is also called Sustiva®. It is manufactured

by Bristol-Myers Squibb.

Efavirenz is a non-nucleoside reverse transcriptase inhibitor

(a “non-nuke” or NNRTI). These drugs stop HIV from multiplying

by preventing the reverse transcriptase enzyme from working. This

enzyme changes HIV’s genetic material (RNA) into the form of DNA.

This step has to occur before HIV’s genetic code gets inserted

into an infected cell’s genetic codes.


WHO SHOULD TAKE

IT?

Efavirenz was approved as an antiviral drug for people with HIV

infection. There are no absolute rules about when to start antiviral

drugs. You and your doctor should consider your T-cell count,

your viral load, any symptoms you are having, and your attitude

about taking HIV medications. Fact

Sheet 411 has more information about guidelines

for the use of antiviral medications.

If you take efavirenz with other antiviral drugs, you can reduce

your viral load to extremely low levels, and increase your T-cell

counts. This should mean staying healthier longer.

Efavirenz seems to get into the central nervous system (spinal

fluid). It may help prevent mental problems such as dementia.


WHAT ABOUT DRUG

RESISTANCE?

Many new copies of HIV are mutations. They are slightly different

from the original virus. Some mutations can keep multiplying

even when you are taking an antiviral drug. When this happens,

the drug will stop working. This is called “developing resistance”

to the drug. See Fact Sheet 414

for more information on resistance.

Sometimes, if your virus develops resistance to one drug, it

will also have resistance to other antiviral drugs. This is called

“cross-resistance”. Cross-resistance among NNRTIs develops

very easily. If you develop resistance to one NNRTI, you probably

won’t be able to use any of them in your antiviral therapy.

Resistance can develop quickly. It is very important to

take antiviral medications according to instructions, on schedule,

and not to skip or reduce doses.


HOW IS IT TAKEN?

Efavirenz is taken by mouth as a capsule. The normal adult dose

is 600 milligrams (mg) once a day at bedtime. Efavirenz is available

in capsules of 50 mg, 100 mg, and 200 mg. Most adults will take

3 of the 200 mg capsules at a time. A 600 mg tablet of efavirenz

was approved in early 2002.

It is recommended that you take efavirenz on an empty stomach,

at bedtime. This dosing should result in the fewest side effects.


WHAT ARE THE SIDE

EFFECTS?

When you start any antiviral treatment, you may have temporary

side effects such as headaches, high blood pressure, or just feeling

ill. These side effects usually get better or disappear over time.

The most common side effects of Efavirenz are rash, nausea,

dizziness, diarrhea, headache and insomnia. Taking efavirenz with

food increases drug levels and may increase side effects. To avoid

dizziness after taking Efavirenz, take it before you go to sleep.

Some people have vivid dreams when taking Efavirenz. For most

people, these side effects disappear within the first two weeks.

Studies in monkeys showed that Efavirenz is likely to cause

birth defects. Pregnant women should not take it.

People who take Efavirenz may falsely test positive for marijuana

use. To prove that the results are false, you would have to identify

the drug that you are taking. This would mean disclosing that

you have HIV infection.


HOW DOES IT REACT

WITH OTHER DRUGS?

Efavirenz is broken down by the liver and can interact with other

drugs that also use the liver. Combining these drugs can change

the amount of each drug in your bloodstream and cause an under-

or overdose. Drugs to watch out for include several antihistamines,

sedatives, and anti-fungal drugs. Make sure that your doctor knows

about ALL drugs you are taking.

  • Efavirenz lowers blood levels of most protease inhibitors.

    Your doctor will need to increase your dosage of indinavir

    or amprenavir. Efavirenz and

    saquinavir should not be used

    together.

  • Efavirenz decreases blood levels of methadone. People using

    both drugs will need to increase their dosage of methadone.


Revised February 7, 2002

HomeGo

to InfoNet Main Page

Card FileGo to

Index of Fact Sheets

Question markClick

here if you have questions

The New Mexico AIDS InfoNet is a project of the

New Mexico AIDS Education and Training Center

Partially funded by the National Library of Medicine

and the New Mexico Department of Health